CME Price Prediction Next Week
Technical Analysis: CME's stock shows strong bullish momentum with RSI-14 at 62.37, indicating room for further upside. The stock is trading above all major moving averages (5,10,20,60,200-day SMAs), confirming an uptrend. The MACD (4.00) and positive MACD histogram (0.53) suggest continued bullish momentum.
Price Levels & Targets:
- Current price: $248.49
- Fibonacci resistance levels: R1: $251.98, R2: $255.25, R3: $260.53
- Fibonacci support levels: S1: $241.42, S2: $238.15, S3: $232.87
- Bollinger Bands show price trading in upper band region (BBP: 0.69), suggesting strong momentum
News Impact:
- Recent Q4 earnings beat expectations with EPS of $2.52 vs $2.45 estimated
- Multiple analyst upgrades:
- RBC Capital raised PT to $269
- Barclays raised PT to $263
- Strong institutional interest with 5.45% increase in hedge fund holdings
Price Prediction (Next Week): Based on technical indicators and positive news sentiment, CME is likely to test Fibonacci R1 at $251.98. The stock should maintain support above $241.42 (S1).
Recommendation: BUY Entry: Current market price ($248.49) Target: $251.98 (R1) Stop Loss: $241.42 (S1)
CME Similar Chart Price Prediction
The price of CME is predicted to go up -7.32%, based on the high correlation periods with IBM. The similarity of these two price pattern on the periods is 98.17%.
CME
IBM
Down: -7.32%Similarity: 98.17%
CME Revenue Forecast
CME EPS Forecast
CME FAQs
What is bull’s view on CME?
What is bear's view on CME?
What is CME revenue forecast for next quarter？
What is CME eps forecast for next quarter？
CME VS S&P500
CME has assembled a diverse set of derivative products in interest rates, equities, commodities, metals, and foreign currency. Weakness in one product is often offset by strength in another.
CME has been able drive trading volume growth by successfully introducing new futures contracts, like the micro E-mini S&P 500 and SOFR futures.
CME stands to be a beneficiary of rising rates as increased volatility drives more trading volume in its interest rate futures contracts.
CME Analyst's Forecast
Mike Cyprys
Morgan Stanley
Hold
2025-02-19
Price Target
$256 → $263
Upside
+4.89%
Morgan Stanley raised the firm's price target on CME Group to $263 from $256 and keeps an Equal Weight rating on the shares. In a model refresh following Q4 results, the firm is raising its 2025 adjusted EPS view by 3.6% to $10.97 from $10.59.
Kyle Voigt
Keefe, Bruyette & Woods
Hold
2025-02-14
Price Target
$256 → $257
Upside
+4.69%
Owen Lau
Oppenheimer
Buy
2025-02-13
Price Target
$258 → $269
Upside
+7.55%
